{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:40:19Z","timestamp":1790174419342,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"crossref","award":["13012"],"award-info":[{"award-number":["13012"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"crossref","award":["13011"],"award-info":[{"award-number":["13011"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Protein kinase C\u03b2 (PKC\u03b2) expressed in mammalian cells as two splice variants, PKC\u03b2I and PKC\u03b2II, functions in the B cell receptor (BCR) signaling pathway and contributes to B cell development. We investigated the relative role of PKC\u03b2II in B cells by generating transgenic mice where expression of the transgene is directed to these cells using the E\u00b5 promoter (E\u00b5-PKC\u03b2IItg). Our findings demonstrate that homozygous E\u00b5-PKC\u03b2IItg mice displayed a shift from IgD<jats:sup>+<\/jats:sup>IgM<jats:sup>dim<\/jats:sup>toward IgD<jats:sup>dim<\/jats:sup>IgM<jats:sup>+<\/jats:sup>B cell populations in spleen, peritoneum and peripheral blood. Closer examination of these tissues revealed respective expansion of marginal zone (MZ)-like B cells (IgD<jats:sup>+<\/jats:sup>IgM<jats:sup>+<\/jats:sup>CD43<jats:sup>neg<\/jats:sup>CD21<jats:sup>+<\/jats:sup>CD24<jats:sup>+<\/jats:sup>), increased populations of B-1 cells (B220<jats:sup>+<\/jats:sup>IgD<jats:sup>dim<\/jats:sup>IgM<jats:sup>+<\/jats:sup>CD43<jats:sup>+<\/jats:sup>CD24<jats:sup>+<\/jats:sup>CD5<jats:sup>+<\/jats:sup>), and higher numbers of immature B cells (IgD<jats:sup>dim<\/jats:sup>IgM<jats:sup>dim<\/jats:sup>CD21<jats:sup>neg<\/jats:sup>) at the expense of mature B cells (IgD<jats:sup>+<\/jats:sup>IgM<jats:sup>+<\/jats:sup>CD21<jats:sup>+<\/jats:sup>). Therefore, the overexpression of PKC\u03b2II, which is a phenotypic feature of chronic lymphocytic leukaemia cells, can skew B cell development in mice, most likely as a result of a regulatory influence on BCR signaling.<\/jats:p>","DOI":"10.1038\/s41598-020-70191-y","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T10:04:15Z","timestamp":1596535455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A novel transgenic mouse strain expressing PKC\u03b2II demonstrates expansion of B1 and marginal zone B cell populations"],"prefix":"10.1038","volume":"10","author":[{"given":"Ali A.","family":"Azar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-475X","authenticated-orcid":false,"given":"Alison M.","family":"Michie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Tarafdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1768-3544","authenticated-orcid":false,"given":"Natasha","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha K.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen J.","family":"Till","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolina","family":"Vlatkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-9004","authenticated-orcid":false,"given":"Joseph R.","family":"Slupsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"70191_CR1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrc.2017.121","volume":"18","author":"JA Burger","year":"2018","unstructured":"Burger, J. A. & Wiestner, A. Targeting B cell receptor signalling in cancer: Preclinical and clinical advances. Nat. Rev. Cancer 18, 148\u2013167 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"70191_CR2","doi-asserted-by":"crossref","unstructured":"Yam-Puc, J., Zhang, L., Zhang, Y. & Toellner, K. Role of B-cell receptors for B-cell development and antigen-induced differentiation. F1000Research 7, (2018).","DOI":"10.12688\/f1000research.13567.1"},{"key":"70191_CR3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni1097","volume":"5","author":"M Spitaler","year":"2004","unstructured":"Spitaler, M. & Cantrell, D. A. Protein kinase C and beyond. Nat. Immunol. 5, 785\u2013790 (2004).","journal-title":"Nat. Immunol."},{"key":"70191_CR4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.273.5276.788","volume":"273","author":"M Leitges","year":"1996","unstructured":"Leitges, M. et al. Immunodeficiency in protein kinase c\u03b2-deficient mice. Science 273, 788\u2013791 (1996).","journal-title":"Science"},{"key":"70191_CR5","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1093\/emboj\/20.20.5692","volume":"20","author":"SW Kang","year":"2001","unstructured":"Kang, S. W. et al. PKC\u03b2 modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J. 20, 5692\u20135702 (2001).","journal-title":"EMBO J."},{"key":"70191_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/1074-7613(95)90115-9","volume":"3","author":"JD Kerner","year":"1995","unstructured":"Kerner, J. D. et al. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3, 301\u2013312 (1995).","journal-title":"Immunity"},{"key":"70191_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/1074-7613(95)90114-0","volume":"3","author":"WN Khan","year":"1995","unstructured":"Khan, W. N. et al. Defective B-cell development and function in Btk-deficient mice. Immunity 3, 283\u2013299 (1995).","journal-title":"Immunity"},{"key":"70191_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/2001\/28962","volume":"8","author":"A Maas","year":"2001","unstructured":"Maas, A. & Hendriks, R. W. Role of Bruton\u2019s tyrosine kinase in B cell development. Dev. Immunol. 8, 171\u2013181 (2001).","journal-title":"Dev. Immunol."},{"key":"70191_CR9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/dna.1987.6.389","volume":"6","author":"L Coussens","year":"1987","unstructured":"Coussens, L., Rhee, L., Parker, P. J. & Ullrich, A. Alternative splicing increases the diversity of the human protein kinase C family. DNA 6, 389\u2013394 (1987).","journal-title":"DNA"},{"key":"70191_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0014-5793(87)80524-0","volume":"223","author":"K Kubo","year":"1987","unstructured":"Kubo, K., Ohno, S. & Suzuki, K. Primary structures of human protein kinase C beta I and beta II differ only in their C-terminal sequences. FEBS Lett. 223, 138\u2013142 (1987).","journal-title":"FEBS Lett."},{"key":"70191_CR11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood-2006-03-012021","volume":"109","author":"ST Abrams","year":"2007","unstructured":"Abrams, S. T. et al. B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase C\u03b2II. Blood 109, 1193\u20131201 (2007).","journal-title":"Blood"},{"key":"70191_CR12","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2008-06-160713","volume":"113","author":"C Holler","year":"2009","unstructured":"Holler, C. et al. PKC\u03b2 is essential for the development of CLL in the TCL1 transgenic mouse model: Validation of PKC\u03b2 as a therapeutic target in CLL. Blood 113, 2791\u20132794 (2009).","journal-title":"Blood"},{"key":"70191_CR13","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","volume":"117","author":"N Chiorazzi","year":"2011","unstructured":"Chiorazzi, N. & Ferrarini, M. Cellular origin(s) of chronic lymphocytic leukemia: Cautionary notes and additional considerations and possibilities. Blood 117, 1781\u20131791 (2011).","journal-title":"Blood"},{"key":"70191_CR14","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.20120833","volume":"209","author":"M Seifert","year":"2012","unstructured":"Seifert, M. et al. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J. Exp. Med. 209, 2183\u20132198 (2012).","journal-title":"J. Exp. Med."},{"key":"70191_CR15","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","volume":"99","author":"R Bichi","year":"2002","unstructured":"Bichi, R. et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc. Natl. Acad. Sci. USA 99, 6955\u20136960 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70191_CR16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","volume":"17","author":"U Klein","year":"2010","unstructured":"Klein, U. et al. The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17, 28\u201340 (2010).","journal-title":"Cancer Cell"},{"key":"70191_CR17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ccr.2004.08.033","volume":"6","author":"L Planelles","year":"2004","unstructured":"Planelles, L. et al. APRIL promotes B-1 cell-associated neoplasm. Cancer Cell 6, 399\u2013408 (2004).","journal-title":"Cancer Cell"},{"key":"70191_CR18","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1073\/pnas.1007186107","volume":"107","author":"U Santanam","year":"2010","unstructured":"Santanam, U. et al. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc. Natl. Acad. Sci. USA. 107, 12210\u201312215 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"70191_CR19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1042\/BST0351009","volume":"035","author":"AM Michie","year":"2007","unstructured":"Michie, A. M., Nakagawa, R. & McCaig, A. M. Murine models for chronic lymphocytic leukaemia. Biochem. Soc. Trans. 035, 1009\u20131012 (2007).","journal-title":"Biochem. Soc. Trans."},{"key":"70191_CR20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/leu.2009.287","volume":"24","author":"TD Shanafelt","year":"2010","unstructured":"Shanafelt, T. D., Ghia, P., Lanasa, M. C., Landgren, O. & Rawstron, A. C. Monoclonal B-cell lymphocytosis (MBL): Biology, natural history and clinical management. Leukemia 24, 512\u2013520 (2010).","journal-title":"Leukemia"},{"key":"70191_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.189.1.123","volume":"189","author":"AC Shaw","year":"1999","unstructured":"Shaw, A. C., Swat, W., Ferrini, R., Davidson, L. & Alt, F. W. Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. J. Exp. Med. 189, 123\u2013129 (1999).","journal-title":"J. Exp. Med."},{"key":"70191_CR22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.122.2.549","volume":"122","author":"KJ Kim","year":"1979","unstructured":"Kim, K. J., Kanellopoulos-Langevin, C., Merwin, R. M., Sachs, D. H. & Asofsky, R. Establishment and characterization of BALB\/c lymphoma lines with B cell properties. J. Immunol. 122, 549\u2013554 (1979).","journal-title":"J. Immunol."},{"key":"70191_CR23","doi-asserted-by":"crossref","first-page":"e1165","DOI":"10.1038\/cddis.2014.120","volume":"5","author":"T Athwal","year":"2014","unstructured":"Athwal, T. et al. Expression of human cationic trypsinogen (PRSS1) in murine acinar cells promotes pancreatitis and apoptotic cell death. Cell Death Dis. 5, e1165 (2014).","journal-title":"Cell Death Dis."},{"key":"70191_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2141.2010.08507.x","volume":"153","author":"AM McCaig","year":"2011","unstructured":"McCaig, A. M., Cosimo, E., Leach, M. T. & Michie, A. M. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. Br. J. Haematol. 153, 199\u2013211 (2011).","journal-title":"Br. J. Haematol."},{"key":"70191_CR25","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1093\/nar\/gki958","volume":"33","author":"M Kozak","year":"2005","unstructured":"Kozak, M. A second look at cellular mRNA sequences said to function as internal ribosome entry sites. Nucleic Acids Res. 33, 6593\u20136602 (2005).","journal-title":"Nucleic Acids Res."},{"key":"70191_CR26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1084\/jem.20051038","volume":"202","author":"B Srivastava","year":"2005","unstructured":"Srivastava, B., Quinn, W. J. III., Hazard, K., Erikson, J. & Allman, D. Characterization of marginal zone B cell precursors. J. Exp. Med. 202, 1225\u20131234 (2005).","journal-title":"J. Exp. Med."},{"key":"70191_CR27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","volume":"9","author":"S Pillai","year":"2009","unstructured":"Pillai, S. & Cariappa, A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9, 767\u2013777 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"70191_CR28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coi.2008.03.014","volume":"20","author":"D Allman","year":"2008","unstructured":"Allman, D. & Pillai, S. Peripheral B cell subsets. Curr. Opin. Immunol. 20, 149\u2013157 (2008).","journal-title":"Curr. Opin. Immunol."},{"key":"70191_CR29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2559.2007.02666.x","volume":"50","author":"AV Decouvelaere","year":"2007","unstructured":"Decouvelaere, A. V., Morschhauser, F., Buob, D., Copin, M. C. & Dumontet, C. Heterogeneity of protein kinase C \u03b22 expression in lymphoid malignancies. Histopathology 50, 561\u2013566 (2007).","journal-title":"Histopathology"},{"key":"70191_CR30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1189\/jlb.2A0714-320R","volume":"97","author":"C Liu","year":"2015","unstructured":"Liu, C. et al. A negative-feedback function of PKC\u03b2 in the formation and accumulation of signaling-active B cell receptor microclusters within B cell immunological synapse. J. Leuk. Biol. 97, 887\u2013900 (2015).","journal-title":"J. Leuk. Biol."},{"key":"70191_CR31","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1182\/blood-2009-06-229872","volume":"115","author":"ST Abrams","year":"2010","unstructured":"Abrams, S. T., Brown, B. R. B., Zuzel, M. & Slupsky, J. R. Vascular endothelial growth factor stimulates protein kinase C\u03b2II expression in chronic lymphocytic leukaemia cells. Blood 115, 4447\u20134454 (2010).","journal-title":"Blood"},{"key":"70191_CR32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.imlet.2006.01.006","volume":"105","author":"C Venkataraman","year":"2006","unstructured":"Venkataraman, C. et al. Selective role of PKC\u03b2 enzymatic function in regulating cell survival mediated by B cell antigen receptor cross-linking. Immunol. Lett. 105, 83\u201389 (2006).","journal-title":"Immunol. Lett."},{"key":"70191_CR33","first-page":"1375","volume":"61","author":"Y G\u00f6kmen-Polar","year":"2001","unstructured":"G\u00f6kmen-Polar, Y., Murray, N. R., Velasco, M. A., Gatalica, Z. & Fields, A. P. Elevated protein kinase C\u03b2II is an early promotive event in colon carcinogenesis. Cancer Res.. 61, 1375\u20131381 (2001).","journal-title":"Cancer Res.."},{"key":"70191_CR34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1083\/jcb.145.4.699","volume":"145","author":"NR Murray","year":"1999","unstructured":"Murray, N. R. et al. Overexpression of protein kinase C\u03b2II induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J. Cell Biol. 145, 699\u2013711 (1999).","journal-title":"J. Cell Biol."},{"key":"70191_CR35","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1084\/jem.20070379","volume":"204","author":"H Shinohara","year":"2007","unstructured":"Shinohara, H., Maeda, S., Watarai, H. & Kurosaki, T. I\u03baB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells. J. Exp. Med. 204, 3285\u20133293 (2007).","journal-title":"J. Exp. Med."},{"key":"70191_CR36","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20051591","volume":"202","author":"H Shinohara","year":"2005","unstructured":"Shinohara, H. et al. PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. J. Exp. Med. 202, 1423\u20131431 (2005).","journal-title":"J. Exp. Med."},{"key":"70191_CR37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/ni823","volume":"3","author":"TT Su","year":"2002","unstructured":"Su, T. T. et al. PKC-\u03b2 controls I\u03baB kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3, 780\u2013786 (2002).","journal-title":"Nat. Immunol."},{"key":"70191_CR38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1074-7613(01)00135-2","volume":"14","author":"A Cariappa","year":"2001","unstructured":"Cariappa, A. et al. The Follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14, 603\u2013615 (2001).","journal-title":"Immunity"},{"key":"70191_CR39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","volume":"17","author":"EM Bowers","year":"2010","unstructured":"Bowers, E. M. et al. Virtual ligand screening of the p300\/CBP histone acetyltransferase: Identification of a selective small molecule inhibitor. Chem. Biol. 17, 471\u2013482 (2010).","journal-title":"Chem. Biol."},{"key":"70191_CR40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H","volume":"32","author":"T Samardzic","year":"2002","unstructured":"Samardzic, T. et al. Reduction of marginal zone B cells in CD22-deficient mice. Eur. J. Immunol. 32, 561\u2013567 (2002).","journal-title":"Eur. J. Immunol."},{"key":"70191_CR41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1084\/jem.177.4.999","volume":"177","author":"D Gay","year":"1993","unstructured":"Gay, D., Saunders, T., Camper, S. & Weigert, M. Receptor editing: An approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177, 999\u20131008 (1993).","journal-title":"J. Exp. Med."},{"key":"70191_CR42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/337562a0","volume":"337","author":"DA Nemazee","year":"1989","unstructured":"Nemazee, D. A. & Burki, K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562\u2013566 (1989).","journal-title":"Nature"},{"key":"70191_CR43","unstructured":"Azar, A. A. Generation of PKC\u03b2II transgenic mice for the study of chronic lymphocytic leukaemia Ph.D. thesis, University of Liverpool (2013)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70191-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T07:37:25Z","timestamp":1696491445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70191-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70191"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70191-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JRS has received funding from Verastem Inc., and has a collaborative relationship with the Netherlands Translational Research Center B.V. The other authors of this manuscript have no potential competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13156"}}